Same-day mastectomy and axillary lymph node dissection is safe for most patients with breast cancer

被引:7
|
作者
Tamminen, Anselm [1 ]
Meretoja, Tuomo [2 ,3 ]
Koskivuo, Ilkka [1 ]
机构
[1] Univ Turku, Turku Univ Hosp, Dept Plast & Gen Surg, Turku, Finland
[2] Helsinki Univ Helsinki, Breast Surg Unit, Ctr Comprehens Canc, Helsinki, Finland
[3] Univ Helsinki, Helsinki, Finland
关键词
complications; day surgery; mastectomy; safety; OUTPATIENT MASTECTOMY; AMBULATORY SURGERY; RADICAL-MASTECTOMY; FOLLOW-UP; OUTCOMES; CARE;
D O I
10.1002/jso.26799
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objective The aim of this study was to evaluate the safety of same-day mastectomy, with or without a sentinel node biopsy (SNB) and/or axillary lymph node dissection (ALND). Methods In this retrospective study, we reviewed 913 consecutive women who underwent a simple mastectomy for breast cancer between the years 2014 and 2019 and were treated either with same-day surgery (SDS) or an overnight stay (OS) regime. We reviewed all surgical complications, any unplanned return to care (RTC) and the rehospitalization rate for 30 postoperative days. Results A total of 259 patients (28%) were treated with SDS and 654 patients (72%) with an OS regime. There was no difference in RTC (odds ratio: 0.79 [95% confidence interval: 0.53-1.18], p = 0.26) or any major complications between the groups. None of the investigated subgroups, such as patients with previous neoadjuvant therapy, diabetes, obesity (up to a body mass index of 40 kg/m(2)), the American Society of Anaesthesiologist Class of 3, or elderly patients aged 75-84 years, showed an increased complication rate when treated with the SDS regime. Conclusion A same-day simple mastectomy is safe with SNB and/or ALND. It can be performed safely for most patients with stable co-morbidities.
引用
收藏
页码:831 / 838
页数:8
相关论文
共 50 条
  • [41] Axillary lymph node dissection in breast cancer: An evolving question?
    Lagares-Garcia, JA
    Garguilo, G
    Kurek, S
    LeBlond, G
    Diaz, F
    AMERICAN SURGEON, 2000, 66 (01) : 66 - 72
  • [42] The changing role of axillary lymph node dissection for breast cancer
    Masakuni Noguchi
    Emi Morioka
    Yukako Ohno
    Miki Noguchi
    Yasuharu Nakano
    Takeo Kosaka
    Breast Cancer, 2013, 20 : 41 - 46
  • [43] The changing role of axillary lymph node dissection for breast cancer
    Noguchi, Masakuni
    Morioka, Emi
    Ohno, Yukako
    Noguchi, Miki
    Nakano, Yasuharu
    Kosaka, Takeo
    BREAST CANCER, 2013, 20 (01) : 41 - 46
  • [44] Breast cancer: Can axillary lymph node dissection be avoided?
    Barry, M.
    Kell, M. R.
    EJSO, 2012, 38 (01): : 6 - 7
  • [45] Impact of Axillary Lymph Node Dissection on Breast Cancer Outcome in Clinically Node Negative Patients
    Sanghani, Mona
    Balk, Ethan M.
    Cady, Blake
    CANCER, 2009, 115 (08) : 1613 - 1620
  • [46] Is axillary lymph node dissection always necessary in breast cancer patients with a positive sentinel node?
    Coutant, C.
    Morel, O.
    Antoine, M.
    Uzan, S.
    Barranger, E.
    JOURNAL DE CHIRURGIE, 2007, 144 (06): : 492 - 501
  • [47] Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer
    Noguchi, M.
    EJSO, 2008, 34 (02): : 129 - 134
  • [48] Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique - Implications for patients with breast cancer
    Silberman, AW
    McVay, C
    Cohen, JS
    Altura, JF
    Brackert, S
    Sarna, GP
    Palmer, D
    Ko, A
    Memsic, L
    ANNALS OF SURGERY, 2004, 240 (01) : 1 - 6
  • [49] Predictors of Completion Axillary Lymph Node Dissection in Patients With Immunohistochemical Metastases to the Sentinel Lymph Node in Breast Cancer
    Pugliese, Matthew S.
    Karam, Amer K.
    Hsu, Meier
    Stempel, Michelle M.
    Patil, Sujata M.
    Ho, Alice Y.
    Traina, Tiffany A.
    Van Zee, Kimberly J.
    Cody, Hiram S., III
    Morrow, Monica
    Gemignani, Mary L.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (04) : 1063 - 1068
  • [50] Is axillary Lymph Node Dissection necessary after Sentinel-Lymph Node-Biopsy in Patients with Mastectomy and pathological N1 Breast Cancer?
    Krug, David
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (03) : 291 - 293